Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1972 Sep;69(9):2701–2705. doi: 10.1073/pnas.69.9.2701

Specific Suppression of the Antibody Response by Antibodies to Receptors

Humberto Cosenza 1, Heinz Köhler 1
PMCID: PMC427020  PMID: 4403565

Abstract

Balb/c myeloma proteins, TEPC 15 and MOPC 167, bind phosphorylcholine and precipitate with the C-polysaccharide moiety of pneumococci R36A. Anti-idiotypic antibodies to TEPC 15 myeloma raised in A/He mice prevent plaque formation by cells releasing antibody to phosphorylcholine and inhibit induction of the antibody response to phosphorylcholine in vitro and in vivo. This suppression is specific since antibodies against non-crossreacting idiotypic determinants of MOPC 167 do not prevent either formation of plaques or induction of the antibody response. Furthermore, the response to sheep erythrocytes is not suppressed by antibodies to TEPC 15. These results indicate that antibodies to phosphorylcholine and cell receptors for phosphorylcholine share similar antigen-binding sites with TEPC 15 myeloma protein. Thus, anti-idiotypic antibodies directed against TEPC 15 myeloma protein function as “anti-receptor” antibodies since they specifically prevent induction of the primary response to phosphorylcholine. It is proposed that antibodies to receptors may be involved in the homeostasis of the immune response.

Keywords: plasmacytomas, phosphorylcholine, anti-idiotypic antiserum, homeostasis

Full text

PDF
2701

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ada G. L., Byrt P. Specific inactivation of antigen-reactive cells with 125I-labelled antigen. Nature. 1969 Jun 28;222(5200):1291–1292. doi: 10.1038/2221291a0. [DOI] [PubMed] [Google Scholar]
  2. Chesebro B., Metzger H. Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry. 1972 Feb 29;11(5):766–771. doi: 10.1021/bi00755a014. [DOI] [PubMed] [Google Scholar]
  3. Cosenza H., Köhler H. Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science. 1972 Jun 2;176(4038):1027–1029. doi: 10.1126/science.176.4038.1027. [DOI] [PubMed] [Google Scholar]
  4. Cosenza H., Leserman L. D., Rowley D. A. The third cell type required for the immune response of spleen cells in vitro. J Immunol. 1971 Aug;107(2):414–421. [PubMed] [Google Scholar]
  5. Jerne N. K., Nordin A. A. Plaque Formation in Agar by Single Antibody-Producing Cells. Science. 1963 Apr 26;140(3565):405–405. doi: 10.1126/science.140.3565.405. [DOI] [PubMed] [Google Scholar]
  6. Köhler H., Shimizu A., Paul C., Moore V., Putnam F. W. Three variable-gene pools common to IgM, IgG and IgA immunoglobulins. Nature. 1970 Sep 26;227(5265):1318–1320. doi: 10.1038/2271318a0. [DOI] [PubMed] [Google Scholar]
  7. Lesley J., Dutton R. W. Antigen receptor molecules: inhibition by antiserum against kappa light chains. Science. 1970 Jul 31;169(3944):487–488. doi: 10.1126/science.169.3944.487. [DOI] [PubMed] [Google Scholar]
  8. Manning D. D., Jutila J. W. Immunosuppression of mice injected with heterologous anti-immunoglobulin heavy chain antisera. J Exp Med. 1972 Jun 1;135(6):1316–1333. doi: 10.1084/jem.135.6.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mishell R. I., Dutton R. W. Immunization of normal mouse spleen cell suspensions in vitro. Science. 1966 Aug 26;153(3739):1004–1006. doi: 10.1126/science.153.3739.1004. [DOI] [PubMed] [Google Scholar]
  10. Mäkelä O. Analogies between lymphocyte receptors and the resulting humoral antibodies. Transplant Rev. 1970;5:3–18. [PubMed] [Google Scholar]
  11. Pernis B., Forni L., Amante L. Immunoglobulin spots on the surface of rabbit lymphocytes. J Exp Med. 1970 Nov;132(5):1001–1018. doi: 10.1084/jem.132.5.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Plotz P. H., Talal N., Asofsky R. Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes. J Immunol. 1968 Apr;100(4):744–751. [PubMed] [Google Scholar]
  13. Sell S., An T. Studies on rabbit lymphocytes in vitro. XIV. Fractionation of rabbit peripheral blood lymphocytes by antibody-coated polyacrylamide beads. J Immunol. 1971 Nov;107(5):1302–1313. [PubMed] [Google Scholar]
  14. Sherr C. J., Baur S., Grundke I., Zeligs J., Zeligs B., Uhr J. W. Cell surface immunoglobulin. 3. Isolation and characterization of immunoglobulin from nonsecretory human lymphoid cells. J Exp Med. 1972 Jun 1;135(6):1392–1405. doi: 10.1084/jem.135.6.1392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sirisinha S., Eisen H. N. Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. Proc Natl Acad Sci U S A. 1971 Dec;68(12):3130–3135. doi: 10.1073/pnas.68.12.3130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vitetta E. S., Baur S., Uhr J. W. Cell surface immunoglobulin. II. Isolation and characterization of immunoglobulin from mouse splenic lymphocytes. J Exp Med. 1971 Jul 1;134(1):242–264. doi: 10.1084/jem.134.1.242. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES